Is there a role for urine cytology following BCG therapy for non-muscle-invasive bladder cancer (NMIBC)?

404Background: Voided urine cytology has been used as an adjunct in the diagnosis of non-muscle invasive bladder cancer (NMIBC), with a sensitivity and specificity ranging between 13-75% and 76-100...